Please assess the completion status of the following clinical trial:

Trial Title: Efficacy Study of Vaginal Mifepristone to Treat Uterine Fibroids

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Uninterested in fertility during the study.~* Premenopausal status.~* Active symptoms related to uterine fibroids.~* Subjects will be obligated to use non hormonal contraceptives during the study.~Exclusion Criteria:~* Abnormal liver and renal function~* Participants with significant increase in uterine fibroids size during a short time.~* Exclusionary health problems contraindicating mifepristone included adrenal disease; sickle cell anemia; severe liver, respiratory, or renal disease; and blood clotting defect.~* Current use of steroids, anticoagulants, herbals, or botanicals with possible hormonal effects.

- Gender: FEMALE
- Minimum Age: 30 Years
- Maximum Age: 53 Years
- Healthy Volunteers: f

Study Arms:
- antiprogestin (Type: EXPERIMENTAL): Daily use of 10 mg administrated per vagina

Based on this trial design, predict the completion outcome and termination type (if applicable).